Back to the peptide atlas
MitochondriaPeptideApproved for specific uses

Elamipretide

Cardiolipin binding

Also known as: SS-31 · Forzinity

No account · this device only

The essentials at a glance

Classification
Peptide · Mitochondria
Mechanism
Mitochondrial cardiolipin-binding tetrapeptide
Evidence
Established
Status
Approved for specific uses

Binds mitochondrial cardiolipin; accelerated U.S. approval covers a narrowly defined rare disease.

Distinction: Elamipretide is approved for a narrowly defined rare disease, unlike the unregulated MOTS-c.

Evidence strengthEstablished

The described biological role is well established, or extensive regulator-reviewed human data exist for clearly defined products and uses. This does not automatically transfer to other products or purposes.

Approved for specific uses: Prescription active ingredient for defined indications in at least one jurisdiction; not offered here.

Research questions

Mechanism: Elamipretide

01

Cardiolipin binding

This studies how a peptide binds to a special fat molecule in the mitochondrial membrane and supports its stability, similar to a repair clamp on a damaged structure. Cell stress markers and mitochondrial function are measured.

02

Mitochondrial peptide

Researchers study how a peptide interacts with the cell's power plants, the mitochondria, and affects their energy production. Measures include oxygen consumption and energy turnover in cell models.

03

Cellular energy metabolism

Researchers study how cells produce and use energy, particularly through the mitochondria, similar to measuring how efficiently an engine burns fuel. Typical measures include oxygen consumption and energy output in cell models.

Simple example

Approved prescription drug

Think of it like a product that has gone through a defined review process, similar to a vehicle that has passed a technical inspection.

Even approval covers only the reviewed indication and dosing regimen and does not guarantee an individual outcome.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Biohacker and longevity forums

Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.

Anti-aging forums

Combinations of growth-axis, mitochondrial, and skin peptides are compared here with the goal of influencing visible or felt signs of ageing, often documented personally over years. Anecdotes and vendor advertising about slowed ageing are not scientific proof.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Evidence boundary

The accelerated approval covers only the specific indication.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.